Clincosm LogoSign in Get a demo

Refractory Multiple Myeloma

Showing 26 - 50 of 105
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Relapsed Multiple Myeloma, Refractory Multiple Myeloma Trial in Canada, United States (Ixazomib, Lenalidomide, Dexamethasone)

Completed
Has Results
  • Relapsed Multiple Myeloma
  • Refractory Multiple Myeloma
  • Little Rock, Arkansas
  • +23 more
Feb 24, 2022

Refractory Multiple Myeloma Trial in United States (Lintuzumab AC 225)

Terminated
  • Refractory Multiple Myeloma
  • Lintuzumab AC 225
  • Los Angeles, California
  • +4 more
Feb 22, 2022

Accelerated Phase Chronic Myelogenous Leukemia, Adult Acute Lymphoblastic Leukemia in Remission, Adult Acute Myeloid Leukemia in

Active, not recruiting
  • Accelerated Phase Chronic Myelogenous Leukemia
  • +125 more
  • tetanus-CMV fusion peptide vaccine
  • laboratory biomarker analysis
  • Duarte, California
    City of Hope Medical Center
Feb 28, 2022

Multiple Myeloma, Relapse Multiple Myeloma, Refractory Multiple Myeloma Trial in Shenzhen (BCMA CAR-T cells)

Recruiting
  • Multiple Myeloma
  • +2 more
  • BCMA CAR-T cells
  • Shenzhen, Guangdong, China
    Li Yu
Dec 7, 2021

Multiple Myeloma, Multiple Myeloma in Relapse, Refractory Multiple Myeloma Trial in Boston (TriPRIL CAR T Cells,

Recruiting
  • Multiple Myeloma
  • +2 more
  • TriPRIL CAR T Cells
  • +2 more
  • Boston, Massachusetts
    Massachusetts General Hospital Cancer Center
Oct 28, 2021

Multiple Myeloma, Refractory Multiple Myeloma, Multiple Myeloma in Relapse Trial in Boston (Daratumumab, Carfilzomib,

Recruiting
  • Multiple Myeloma
  • +3 more
  • Boston, Massachusetts
  • +2 more
Oct 28, 2021

Relapsed Multiple Myeloma, Refractory Multiple Myeloma Trial in United States (ION251)

Recruiting
  • Relapsed Multiple Myeloma
  • Refractory Multiple Myeloma
  • Birmingham, Alabama
  • +11 more
Oct 13, 2021

Refractory Multiple Myeloma Trial in Germany (MLN9708, Pomalidomide 4 MG Oral Capsule, Dexamethasone)

Recruiting
  • Refractory Multiple Myeloma
  • Munich, Bayern, Germany
  • +10 more
Sep 8, 2021

Refractory Multiple Myeloma Trial in Switzerland (Pomalidomide, Dexamethasone)

Terminated
  • Refractory Multiple Myeloma
  • Aarau, Switzerland
  • +15 more
Jun 7, 2021

Multiple Myeloma in Relapse, Refractory Multiple Myeloma, Plasmacytoid; Lymphoma Trial in Shenzhen, Chengdu (BCMA-CD19 cCAR T

Recruiting
  • Multiple Myeloma in Relapse
  • +2 more
  • BCMA-CD19 cCAR T cells
  • Shenzhen, Guangdong, China
  • +1 more
May 17, 2021

Relapsed Multiple Myeloma, Refractory Multiple Myeloma Trial in Boston, Danvers, Newton (Nivolumab, Ixazomib, Dexamethasone)

Active, not recruiting
  • Relapsed Multiple Myeloma
  • Refractory Multiple Myeloma
  • Boston, Massachusetts
  • +2 more
May 14, 2021

Adult Grade III Lymphomatoid Granulomatosis, B-cell Chronic Lymphocytic Leukemia, Contiguous Stage II Adult Burkitt Lymphoma

Completed
Has Results
  • Adult Grade III Lymphomatoid Granulomatosis
  • +88 more
  • Detroit, Michigan
    Barbara Ann Karmanos Cancer Institute
Apr 14, 2021

Refractory Multiple Myeloma, Smoldering Multiple Myeloma, Stage I Multiple Myeloma Trial in Duarte (radiation, drug, procedure,

Completed
Has Results
  • Refractory Multiple Myeloma
  • +4 more
  • total marrow irradiation
  • +8 more
  • Duarte, California
    City of Hope Medical Center
Feb 25, 2021

Adult Acute Lymphoblastic Leukemia in Remission, Adult Acute Myeloid Leukemia in Remission, Adult Acute Myeloid Leukemia With

Active, not recruiting
  • Adult Acute Lymphoblastic Leukemia in Remission
  • +46 more
  • Philadelphia, Pennsylvania
    Thomas Jefferson University
Feb 10, 2021

Refractory Multiple Myeloma Trial in Spain (Selinexor, Daratumumab, Bortezomib)

Recruiting
  • Refractory Multiple Myeloma
  • Badalona, Spain
  • +14 more
Feb 3, 2021

Relapse Multiple Myeloma, Refractory Multiple Myeloma Trial in Hangzhou (BCMA Targeted CAR T-cells)

Not yet recruiting
  • Relapse Multiple Myeloma
  • Refractory Multiple Myeloma
  • BCMA Targeted CAR T-cells
  • Hangzhou, Zhejiang, China
    The First Affiliated Hospital, Medical College, Zhejiang Univers
Dec 9, 2020

Refractory Multiple Myeloma Trial in Cleveland (azacitidine, lenalidomide, dexamethasone)

Completed
Has Results
  • Refractory Multiple Myeloma
  • Cleveland, Ohio
  • +1 more
Oct 20, 2020

Refractory Multiple Myeloma, Relapse Multiple Myeloma Trial (Pomalidomide, Dexamethasone, INCB053914 50 mg bis in die (BID))

Withdrawn
  • Refractory Multiple Myeloma
  • Relapse Multiple Myeloma
  • (no location specified)
Aug 17, 2020

Refractory Multiple Myeloma Trial in Scottsdale, Jacksonville, Rochester (pomalidomide, bortezomib, dexamethasone)

Completed
Has Results
  • Refractory Multiple Myeloma
  • Scottsdale, Arizona
  • +2 more
Apr 7, 2020

Multiple Myeloma, Multiple Myeloma in Relapse, Refractory Multiple Myeloma Trial in United States (ACTR087, SEA-BCMA)

Terminated
  • Multiple Myeloma
  • +2 more
  • ACTR087
  • SEA-BCMA
  • Phoenix, Arizona
  • +6 more
Mar 27, 2020

Refractory Multiple Myeloma Trial in United States (bendamustine HCl, lenalidomide, dexamethasone)

Completed
Has Results
  • Refractory Multiple Myeloma
  • bendamustine hydrochloride
  • +2 more
  • Duarte, California
  • +4 more
Feb 10, 2020

Adult Acute Myeloid Leukemia With 11q23 (MLL) Abnormalities, Adult Acute Myeloid Leukemia With Del(5q), Adult Acute Myeloid

Completed
Has Results
  • Adult Acute Myeloid Leukemia With 11q23 (MLL) Abnormalities
  • +99 more
  • alemtuzumab
  • +6 more
  • Denver, Colorado
  • +6 more
Jan 15, 2020

Acute Undifferentiated Leukemia, Adult Nasal Type Extranodal NK/T-cell Lymphoma, Anaplastic Large Cell Lymphoma Trial in

Completed
  • Acute Undifferentiated Leukemia
  • +63 more
  • total-body irradiation
  • +7 more
  • Seattle, Washington
  • +1 more
Jan 17, 2020

Acute Myeloid Leukemia/Transient Myeloproliferative Disorder, Acute Undifferentiated Leukemia, Adult Acute Lymphoblastic

Completed
  • Acute Myeloid Leukemia/Transient Myeloproliferative Disorder
  • +76 more
  • fludarabine phosphate
  • +6 more
  • Tucson, Arizona
  • +10 more
Jan 17, 2020

Adult Nasal Type Extranodal NK/T-cell Lymphoma, Anaplastic Large Cell Lymphoma, Angioimmunoblastic T-cell Lymphoma Trial in

Completed
  • Adult Nasal Type Extranodal NK/T-cell Lymphoma
  • +35 more
  • Duarte, California
  • +4 more
Dec 24, 2019